How PE Investors Can Stay Aggressive Amid M&A Slowdown
Flexible deal structures and long-term pipeline development can help private capital investors stay aggressive, say DealMAX panelists ahead of the conference
Decarbonizing M&A: How Legislation Is Changing the Landscape
The Inflation Reduction Act and other legislative moves are driving growth in the decarbonization space, and dealmakers are taking notice
PE Weekly: Corporate Carve-Outs Span Audio Tech, Education and More
Bose exits its professional A/V business, while other carve-outs emerge
ACG Northeast Member Spotlights
A snapshot of ACG’s Northeast membership and the contributions of its volunteers
Advisors Star in Their Own M&A Show
Investment banks, who usually act in supporting roles in M&A processes, have recently been the subjects of their own deals. Here’s how some of the newly formed advisors are tackling a volatile market.
The New Frontiers of Value Creation
Amid market uncertainty, operators point to pricing strategy, employee retention and cybersecurity as unsung paths to performance improvement
The Future of Investing in Customer Service AI
Valyant AI shares insights into what investors need to know about AI's impact at the drive-through
PE Weekly: Dealmakers Eye Health and Wellness
Health and wellness emerges as popular M&A targets this week, from skincare to fertility to cell therapy
How to Network Like a Pro at DealMAX (or Any Conference)
Three expert tips that will show you how to get the most out of any professional conference you attend
Thematic Investing Brings PE to the Clinical Trials Market
COVID-19 shone a light on a fragmented market. Now private equity firms are building platforms of clinical site businesses with an eye toward improving diversity.